Am. Blasini et al., INCREASED PROPORTION OF RESPONDERS TO A MURINE ANTI-CD3 MONOCLONAL-ANTIBODY OF THE IGG1 CLASS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS(SLE), Clinical and experimental immunology, 94(3), 1993, pp. 423-428
A group of Venezuelan patients with SLE showed an increased proportion
of responders to Leu-4, an anti-CD3 MoAb of the IgG1 class, compared
with ethnically matched non-SLE patients and healthy controls. The rat
e of proliferative responses or IL-2 production induced by MoAb Leu-4,
and the helper effect of macrophages from Leu-4 responders on T cells
from a third-party donor were comparable in patients and controls. No
significant differences in the binding of murine IgG1 molecules by ma
crophages from SLE patients and controls were observed. The proportion
of monocytes/macrophages expressing Fc gamma RI was significantly hig
her in SLE patients. However, the expression of FcRII, the type capabl
e of supporting Leu-4-mediated responses, and of Fc gamma RIII was com
parable in monocytes from SLE patients and controls. Our results sugge
st that Venezuelan patients with SLE may have a genetic predisposition
for the expression of the phenotypic variant of Fc gamma RII capable
of binding murine IgG1 molecules.